# Determination of Carboplatin's Optimal Plasmatic Exposure

> **NCT00145028** · NA · COMPLETED · sponsor: **Institut Claudius Regaud** · enrollment: 400 (estimated)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT00145028
- **Lead sponsor:** Institut Claudius Regaud
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2007-12
- **Final completion:** 2009-02
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2009-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00145028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00145028, "Determination of Carboplatin's Optimal Plasmatic Exposure". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00145028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*